Literature DB >> 21458474

Steroid sulfatase inhibitors: a review covering the promising 2000-2010 decade.

René Maltais1, Donald Poirier.   

Abstract

The steroid sulfatase (STS) plays a major role in the regulation of steroid hormone concentrations in several human tissues and target organs and therefore, represents an interesting target to regulate estrogen and androgen levels implicated in different diseases. In this review article, the emphasis is put on STS inhibitors reported in the fruitful 2000-2010 decade, which consolidated the first ones that were previously developed (1990-1999). The inhibitors reviewed are divided into four categories according to the fact that they are sulfamoylated or not or that they have a steroid nucleus or not. Other topics such as function, localization, structure and mechanism as well as applications of STS inhibitors are also briefly discussed to complement the information on this crucial steroidogenic enzyme and its inhibitors.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458474     DOI: 10.1016/j.steroids.2011.03.010

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  10 in total

1.  Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.

Authors:  Mark P Thomas; Barry V L Potter
Journal:  J Med Chem       Date:  2015-06-12       Impact factor: 7.446

2.  Proton-in-flight mechanism for the spontaneous hydrolysis of N-methyl O-phenyl sulfamate: implications for the design of steroid sulfatase inhibitors.

Authors:  David R Edwards; Richard Wolfenden
Journal:  J Org Chem       Date:  2012-04-18       Impact factor: 4.354

3.  Steroidal ferrocenes as potential enzyme inhibitors of the estrogen biosynthesis.

Authors:  Bianka Edina Herman; János Gardi; János Julesz; Csaba Tömböly; Eszter Szánti-Pintér; Klaudia Fehér; Rita Skoda-Földes; Mihály Szécsi
Journal:  Biol Futur       Date:  2020-06-25

Review 4.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

5.  Hepatic overexpression of steroid sulfatase ameliorates mouse models of obesity and type 2 diabetes through sex-specific mechanisms.

Authors:  Mengxi Jiang; Jinhan He; Heidi Kucera; Nilesh W Gaikwad; Bin Zhang; Meishu Xu; Robert M O'Doherty; Kyle W Selcer; Wen Xie
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

Review 6.  The structural biology of oestrogen metabolism.

Authors:  Mark P Thomas; Barry V L Potter
Journal:  J Steroid Biochem Mol Biol       Date:  2013-01-04       Impact factor: 4.292

Review 7.  The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases.

Authors:  Tea Lanišnik Rižner
Journal:  Front Pharmacol       Date:  2016-02-18       Impact factor: 5.810

8.  In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics.

Authors:  Keely M McNamara; Fouzia Guestini; Torill Sauer; Joel Touma; Ida Rashida Bukholm; Jonas C Lindstrøm; Hironobu Sasano; Jürgen Geisler
Journal:  Br J Cancer       Date:  2018-03-22       Impact factor: 7.640

Review 9.  Recent progress in the development of steroid sulphatase inhibitors - examples of the novel and most promising compounds from the last decade.

Authors:  Mateusz Daśko; Sebastian Demkowicz; Karol Biernacki; Olga Ciupak; Witold Kozak; Maciej Masłyk; Janusz Rachon
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

Review 10.  The Regulation of Steroid Action by Sulfation and Desulfation.

Authors:  Jonathan W Mueller; Lorna C Gilligan; Jan Idkowiak; Wiebke Arlt; Paul A Foster
Journal:  Endocr Rev       Date:  2015-07-27       Impact factor: 19.871

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.